InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab
Go back to InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab| InferX Corporation (NASDAQ: IFRX) | Delayed: 2.13 +0.04 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $0.05 | |||
| Open | $2.11 | 52 Week Low | $0.00 | |||
| Day High | $2.19 | P/E | N/A | |||
| Day Low | $2.11 | EPS | $0.00 | |||
| Volume | 126,158 | |||||
